NCPA Advocates for Medicare Drug Price Negotiation Program Overhaul Due to Pharmacy Cash Flow

With its initial rollout beginning in 2026, the Medicare Drug Price Negotiation Program has caused significant strain on the cash flow of independent pharmacies.

The National Community Pharmacists Association (NCPA) is sounding the alarm over the federal government’s implementation of the Medicare Drug Price Negotiation Program (MDPNP) after a recent survey of its members revealed significant financial distress, according to a news release.

Pharmacies To Face Low Cash Flow For MFP Drugs Until Fixes Emerge

A bill introduced last year aiming to ensure long-term care (LTC) pharmacies can continue to supply and dispense Medicare Part D drugs despite lower prices resulting from the price negotiation program will need to be tweaked to ensure the intended relief is retroactive, according to Alan Rosenbloom, executive director of the Senior Care Pharmacy Coalition (SCPC).

SCPC Applauds Inclusion of PBM Reform in Recent Spending Package Approved by U.S. House & Senate

The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement about the passage of PBM reform:   “SCPC applauds the passage of bipartisan pharmacy benefit manager (PBM) reform legislation by both the U.S. House and Senate, marking a significant step toward greater transparency, accountability, and fairness in the prescription drug marketplace. These […]

SCPC Applauds Inclusion of PBM Reform in Recent Spending Package Approved by U.S. House & Senate

The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement about the passage of PBM reform.

This service comes at a cost. Does Congress care?

For more than two years now, pharmacists who are the sole provider of prescriptions for the nation’s most vulnerable, often chronically ill patients have begged Congress for relief from a devastating pricing change.

SCPC Comments on CMS Proposed Rule Regarding 2027 Medicare Changes

The Senior Care Pharmacy Coalition (SCPC) submitted a comment letter on the CMS Proposed Rule entitled “Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program and Medicare Cost Plan Program.” The full letter is below.

SCPC Applauds PBM Provisions Included in the Consolidated Appropriations Act 2026

The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, released the following statement in support of PBM reform:  “SCPC strongly supports the pharmacy benefit manager (PBM) provisions included in the Consolidated Appropriations Act, 2026, and we commend Congressman Buddy Carter for his leadership in advancing meaningful PBM […]

Provisions Of The Inflation Reduction Act Likely To Destabilize Long-Term Care Pharmacies

Provisions of the Inflation Reduction Act (IRA, signed into law in 2022) affecting long-term care (LTC) pharmacies that went live January 1, 2026, are likely to destabilize the industry, according to a survey of senior care pharmacies.

Op-Ed: A Long-Term Care Crisis for Latino Seniors in California’s Central Valley

For older adult Latinos across California’s rural Central Valley, long-term care is more than a healthcare service — it is a lifeline. It allows our parents and grandparents to age with dignity, surrounded by familiar communities, culture, and family. Today, that lifeline is no longer merely threatened — it has been compromised.